Australia's decision-making framework is dominated by a single-payer that exercises its extraordinary power through HTA. Managing the reality of this power asymmetry is critical for the proponents of change.
Power asymmetry is the biggest issue for advocates of HTA reform
October 28, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The need to break this paradigm if we are serious about meaningful reform
June 22, 2026 - - Latest News -
It seems that one critical stakeholder group is missing in this website design
June 22, 2026 - - Latest News -
May 2026 delivers paediatric dosing flexibility, vaccine decisions, and policy updates
June 22, 2026 - - Latest News -
CSL executive Elizabeth Rex joins AusBiotech board as observer
June 22, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 19 June
June 19, 2026 - - Podcast -
Gilead rushes remdesivir to Uganda to support Ebola response
June 19, 2026 - - Latest News -
Infectious diseases across the lifespan are a hidden burden beyond the acute episode
June 19, 2026 - - Latest News


